You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 2051 to 2075 of about 5861
Next 25
04/23/2014
Call For Brain Tumor Research Grant Proposals
Glioblastoma stem cells: a new target for metformin and arsenic trioxide.
Glioblastoma Vaccine Hits Primary Endpoints in Phase 1
04/18/2014
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC).
UCLA 14th Annual Brain Tumor Conference
Battling Cancer Mind Over Body
Stereotactic biopsy of brainstem lesions: Techniques, efficacy, safety, and disease variation between adults and children: A single institutional series and review.
"Brain Tumor Forum" patient conference
04/16/2014
ERGO: A pilot study of ketogenic diet in recurrent glioblastoma.
Additive homeopathy in cancer patients: Retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna.
New Clinical Trials Finder on Virtualtrials.com
04/13/2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared to temozolomide-chemoradiation for unresectable glioblastoma. Final results of the TEMAVIR study from ANOCEF.
04/12/2014
Interim Clinical Data for Tocagen`s Toca 511 & Toca FC in Patients with High Grade Glioma
Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy.
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
04/09/2014
IBTA Newsletter
Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study.
04/08/2014
Integrin Inhibitor Suppresses Bevacizumab-Induced Glioma Invasion.
04/06/2014
Researchers successfully treat brain tumor with sound waves
04/04/2014
Novocure to Present New Pre-Clinical Data on NovoTTF™ Therapy at the American Association for Cancer Research Annual Meeting 2014
04/03/2014
Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4 and PD-L1 in mice with brain tumors.
Northwest Bio Warns FDA May Throw Out Phase III Brain Cancer Study
03/30/2014
Phase II Trial of 7days on/7 days off temozolmide for recurrent high-grade glioma.
03/27/2014
Scientists find treatment to kill every kind of cancer tumor